To explore the effects of the treatment of PLT, PAIgA, PAIgM, PAIgD and PAIgG levels in children with persistent or chronic ITP

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IIR-16009020

Enrollment

Unknown

Registered

2016-08-13

Start date

2016-07-20

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune thrombocytopenia in children

Interventions

Treatment group and control group: Fuzheng Jiedu Decoction with the small dose of Prednisone Acetate Tablets

control group:Chinese medicinal herb with the small dose of Prednisone Acetate Tablets

Eligibility

Sex/Gender

All

Age

1 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Aged 1--18 years old; 2. Diagnostic criteria for persistent or chronic ITP in children with primary ITP diagnosis and treatment recommendations; 3. The diagnostic criteria of TCM syndrome of Qi failing to control blood purpura; 4. The volunteers, can receive treatment and cooperate with relevant laboratory into the group, and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. PLT<10* 109/L and severe bleeding symptoms; 2. Children with allergic reactions to the use of traditional Chinese medicine; 3. TCM diagnostic classification for heat impairing collaterals and blood heat injuring collaterals, yindeficiency; 4. When combined with serious heart, brain, liver, kidney and other diseases; 5. We should not complete treatment, as the cases except.

Design outcomes

Primary

Measure	Time frame
Platelet associated antibody;	—

Countries

China

Contacts

Public ContactHuanlai Xie

Dongzhimen Hospital of Beijing University of Chinese Medicine

1204519826@qq.com+86 18800100822

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026